SMAD4 Tailored Neoadjuvant Therapy for the Treatment of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma, SMART-PANC Trial

NCT07748611 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Borderline Resectable Pancreatic Ductal Adenocarcinoma
Resectable Pancreatic Ductal Adenocarcinoma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review
DRUG: Fluorouracil
DRUG: Gemcitabine
DRUG: Irinotecan
DRUG: Leucovorin
PROCEDURE: Magnetic Resonance Imaging
DRUG: Nab-paclitaxel
DRUG: Oxaliplatin
RADIATION: Radiation Therapy
PROCEDURE: Surgical Procedure

Sponsor

Northwestern University

Collaborators

[object Object]